基于谱效先导—整合药理学的滇黄精质量标志物研究
批准号:
81960710
项目类别:
地区科学基金项目
资助金额:
35.0 万元
负责人:
俞捷
依托单位:
学科分类:
中药质量评价
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
俞捷
中文摘要
黄精健脾益气、滋阴降火,常用于内热消渴(今糖脂代谢紊乱)等症治疗。云南道地药材滇黄精是药典三个法定品种之一,蕴藏量、产量均有优势,项目组研究了调节糖、脂代谢的活性及新颖机制。然而,其质量评价方法严重滞后于其活性研究与临床应用,仅有其总多糖及总皂苷含量测定,无专属性高的质量评价成分及方法,严重限制该药材应用与开发。项目组提出以滇黄精为研究对象,采用“化学指纹-生物效应”谱效关联分析为先导,筛选其中与调节机体糖、脂代谢功效高度关联的甾体皂苷、黄酮等单体,结合成分的亲缘特异性、结构专属性确定并靶向制备准质量标志物,利用网络药理学、药效学、代谢组学及药物动力学等整合药理学方法对其进行综合评价,确定药动性质良好、对药效贡献度高的滇黄精质量标志物(Q-Marker)。本项目为科学评价滇黄精药材质量奠定基础,阐释其用于糖、脂代谢异常相关疾病治疗的科学依据,对黄精药材的深入开发应用具有重要推动意义。
英文摘要
Polygonati Rhizoma, which could reduce fire, replenishe qi and nourish yin, has been used in the treatment of internal heat and thirst for thousand of years. Polygonatum kingianum Coll. Et Hemsl. is one of the three legal source plants of Polygonati Rhizoma recorded in the Chinese Pharmacopoeia. P. kingianum, as a kind of important "YunYao" has large resource reserves and productions in Yunnan Province. The project team has explored its excellent effects and novel mechanism of regulating glucose and lipid metabolism disorders. However, the limited quality evaluation researches about Polygonati Rhizoma, mainly focused on the determination of total polysaccharides and total saponins, are far behind its great bio-actives and clinic applications. There are no specific quality evaluation substance and no suitable quality evaluation method, which severely limit its application and development. This research aims at find the quality evaluation substances and methods for P. kingianum. The project team proposes that the "chemical fingerprint-biological effect" relationship analysis should be used as the guide to screen and identify the steroid saponins and flavonoids, which are highly correlated with its regulation effect of glucose and lipid metabolism. Phylogenic and structural specificity data will be considered when preparing quasi-quality marker. Then, integrated pharmacology methods, such as network pharmacology, pharmacodynamics, metabolomics and pharmacokinetics will be applied to designate quality marker (Q-Marker) with good pharmacokinetic properties and great contribution to pharmacological efficacy. This project will lay a foundation for scientific evaluation of the quality of P. kingianum and will explain its scientific basis for the treatment of diseases related to abnormal glucose and lipid metabolism. It has important impetus to the wider application of Polygonati Rhizoma.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
DOI:
10.3390/molecules27051463
发表时间:
2022-02-22
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
作者:
[He S, Wang X, Chen J, Li X, Gu W, Zhang F, Cao G, Yu J]
通讯作者:
Yu J
Polysaccharides from Polygonatum kingianum improve glucose and lipid metabolism in rats fed a high fat diet
黄精多糖改善高脂饮食大鼠的糖脂代谢
DOI:
10.1016/j.biopha.2020.109910
发表时间:
2020-05-01
期刊:
BIOMEDICINE & PHARMACOTHERAPY
影响因子:
7.5
作者:
[Gu, Wen, Wang, Yanfang, Yu, Jie]
通讯作者:
Yu, Jie
DOI:
10.3389/fphar.2021.740528
发表时间:
2021
期刊:
Frontiers in pharmacology
影响因子:
5.6
作者:
[Dong J, Gu W, Yang X, Zeng L, Wang X, Mu J, Wang Y, Li F, Yang M, Yu J]
通讯作者:
Yu J
DOI:
10.1016/j.jep.2022.115612
发表时间:
2022-08
期刊:
Journal of ethnopharmacology
影响因子:
5.4
作者:
[Pan-Yue Qin;Ya-Jing Xu;Xiang-Duo Zuo;Jun-Hua Duan;Qiu Bin;Xue-Fang Li;Jing-Ping Li;Yu Jie]
通讯作者:
Pan-Yue Qin;Ya-Jing Xu;Xiang-Duo Zuo;Jun-Hua Duan;Qiu Bin;Xue-Fang Li;Jing-Ping Li;Yu Jie
DOI:
10.1016/j.biopha.2021.112092
发表时间:
2021-08-27
期刊:
BIOMEDICINE & PHARMACOTHERAPY
影响因子:
7.5
作者:
[Mu, Jian-Kang, Zi, Lei, Yang, Xing-Xin]
通讯作者:
Yang, Xing-Xin
共 6 条
茯苓甘草汤驱动白色脂肪组织重塑治疗高脂血症的物质基础与作用机制研究
-
批准号:82574650
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:俞捷
-
依托单位:
基于“线粒体-脂质代谢网络”研究黄精丸干预代谢相关脂肪性肝病作用机制
-
批准号:82174037
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:俞捷
-
依托单位:
基于肠道微生态及其分子信使短链脂肪酸调节的制何首乌改善胰岛素抵抗机制研究
-
批准号:81760733
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2017
-
负责人:俞捷
-
依托单位:
何首乌活性成分二苯乙烯苷保护非酒精性脂肪肝的作用机制研究
-
批准号:81460623
-
项目类别:地区科学基金项目
-
资助金额:45.0万元
-
批准年份:2014
-
负责人:俞捷
-
依托单位:
何首乌的脂代谢调节活性物质基础及作用靶点研究
-
批准号:81060337
-
项目类别:地区科学基金项目
-
资助金额:25.0万元
-
批准年份:2010
-
负责人:俞捷
-
依托单位:
国内基金
海外基金